Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges. The forward movement of the bio/pharmaceutical industry is driven by fast-paced ...

Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented. For some time now, the ...

The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

Biopharma 4.0 is often presented as an all-or-nothing proposition, when in fact its components have all been around for a while and have independent value. It appears the major challenge will be ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Continuous ...

Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...

Continuous casting remains a critical process in modern steel production, whereby molten steel is poured into a mould and solidified into semi-finished forms such as blooms, billets or slabs. This ...